Painful and non-painful effects of low doses of morphine in migraine sufferers partly depend on excitatory amino acids and γ-aminobutyric acid

International Journal of Clinical Pharmacology Research

Volumn 18, Issue 2, 1998, Pages 79-85

  Nicolodi, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; DIAZEPAM; EXCITATORY AMINO ACID; MORPHINE; NALOXONE; OPIATE; OPIATE RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SENSITIVITY; FEMALE; HUMAN; MALE; MEIOSIS; MIGRAINE; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; WELLBEING;

ADULT; CROSS-OVER STUDIES; DIAZEPAM; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIGRAINE DISORDERS; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PAIN; RECEPTORS, OPIOID;

EID: 0031667540     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mogil S.J., Marek P., Flodman P., et al. One or two genetic loci mediate high opiate analgesia in selectively bred mice. Pain, 60, 125, 1995.
2. Moskowitz A.S., Terman G.W., Carter K.R., Morgan M.J., Liebskind J.C. Analgesic, locomotor and lethal effects of morphine in the mouse: strain comparison. Brain Res., 635, 16, 1994.
3. Nicolodi M. Differential sensitivity to morphine challenge in migraine sufferers and headache exempts. Cephalalgia, 16, 297, 1996.
4. Nicolodi M., Volpe A.R., Del Bianco P.L., Sicuteri F. Inheritable and acquired hyperalgesia associated with abnormal opioid receptor setup as opiate addiction preventers. Int. J. Clin. Pharm. Res., XVII (2/3), 85, 1997.
5. Silvan S.P., Ho I.K. γ-aminobutyric acid in morphine analgesia and tolerance. Life Sci., 37, 199, 1985.
6. Rocha L., Tatsukawa K., Chugani H.T., Engel J.J. Benzodiazepine receptor binding following chronic treatment with naloxone, morphine and met-enkephalin in normal rats. Brain Res., 612, 247, 1993.
7. International Headache Society. Classification and diag-nostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia, 8 (7), 1988.
8. Nicolodi M. Chronic naloxone as a potential treatment for migraine enhances morphine-induced miosis. Headache, 32, 348, 1992.
9. Yaksh T.L., Haty G.J., Onofrio B.M. High closes of spinal morphine produce a nonopiate receptor-mediated hyperestesia: clinical and theoretic implications. Anesthesiology, 64, 590, 1986.
10. Frenk H., Watkins LR., Miller J., Mayer D.J. Nonspecific convulsions are induced by morphine but not by D-Ala 2-methionine enkephalinamide at cortical sites. Brain Res., 299, 31, 1984.
11. Arnér S., Meyerson B. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain, 33, 11, 1988.
12. Sicuteri F, Nicolodi M. Redundant pain transmission from functional deafferentation. In: F. Clifford-Rose (Ed.). "Advances in Headache Research and Therapy." Libbey, London, 1987, pp 11-18.
13. Sicuteri F., Nicolodi M., Alessandri M. Visceral and somatic pain automatism in idiopathic headache. In: S. Lipton, A. Tunks, M. Zoppi (Eds.). Raven Press, New York, 1990, pp 133-145.